Invex Therapeutics Ltd (ASX:IXC)
Australia · Delayed Price · Currency is AUD
0.1300
0.00 (0.00%)
May 11, 2026, 9:59 AM AEST
Invex Therapeutics Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|
| Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
|---|
| -0.84 | -0.48 | -1.64 | -7.75 | -3.95 | -2.28 |
| 0.02 | 0.02 | 0.14 | 0.48 | 0.35 | 0.56 |
Other Operating Activities | -0.16 | 0.02 | -0.04 | 0.02 | 0 | 0 |
Change in Accounts Receivable | -0 | -0 | 0.24 | -0.19 | -0.12 | 0.1 |
Change in Accounts Payable | -0.21 | -0.21 | -1.14 | 0.57 | 0.35 | -0.05 |
| -1.19 | -0.65 | -2.44 | -6.87 | -3.38 | -1.68 |
| - | - | - | - | - | 8.65 |
Repurchase of Common Stock | - | - | -14 | - | - | - |
Other Financing Activities | - | - | - | - | - | -0.55 |
| - | - | -14 | - | - | 8.09 |
Foreign Exchange Rate Adjustments | -0.02 | 0 | - | - | - | - |
| -1.21 | -0.65 | -16.45 | -6.87 | -3.38 | 6.42 |
| - | -0.23 | -1.21 | -0.46 | - | - |
| -1.05 | -0.64 | -2.1 | -4.48 | -1.95 | -2.23 |
| -1.05 | -0.64 | -2.1 | -4.48 | -1.95 | -2.23 |
Change in Working Capital | -0.21 | -0.21 | -0.9 | 0.38 | 0.22 | 0.04 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.